Home / Companies / Butterfly Network

BFLY · Updated

Butterfly Network

In the Bet The Decade Portfolio

Butterfly Network makes handheld point-of-care ultrasound devices built on its Ultrasound-on-Chip semiconductor platform, paired with cloud-connected software. In its latest fiscal year (ended 31 December 2025) it reported revenue of $97.6 million and a net loss of $77.1 million, according to its 10-K filed on 27 February 2026. Bet The Decade has covered Butterfly Network in 1 episode, most recently “What Is Butterfly Network Really Worth Now That AI Wants Its Chip?” (9 November 2026).

Business description summarized from 10-K (Item 1, Business), filed 2026-02-27. Figures: SEC EDGAR, retrieved 16 November 2026.

Not financial advice.

Portfolio weight: 0.7% · as of 13 Nov 2026 close · Bet The Decade Portfolio →

Next results: date not announced by the company yet (TBA). Earnings calendar →

Watch: What Is Butterfly Network Really Worth Now That AI Wants Its Chip?

Video thumbnail: What Is Butterfly Network Really Worth Now That AI Wants Its Chip?Watch ▶

Bet The Decade on YouTube, 9 November 2026. The video loads only after you press play. Transcript, chapters and sources →

Thesis & risks

From our episodes

Thesis: “My bottom line: the chip was not the mistake. The chip is the reason AI companies are now paying Butterfly.” From What Is Butterfly Network Really Worth Now That AI Wants Its Chip? (9 November 2026), chapter at 0:00.

Opinion from the video, quoted from the transcript. Price targets and valuation scenarios are never reproduced.

Risks the company lists

  • We have a limited history of generating revenue from sales of our products, and we have incurred significant losses since inception. We anticipate that we will continue to incur losses for at least the next several years as we…
  • Our success depends upon market acceptance of our products and services, our ability to develop and commercialize existing and new products and services and generate revenues, and our ability to identify new markets for our…
  • Medical device development is costly and involves continual technological change, which may render our current or future medical devices obsolete.
  • We are dependent upon the success of our sales and customer acquisition and retention strategies.

Quoted (shortened) from the risk factor summary of its 10-K filed 27 February 2026. The full list is longer; read Item 1A (Risk Factors).

Key data

Official data only. TBD = no verified official source yet.
FieldValueSource
Legal name (SEC)Butterfly Network, Inc.SEC EDGAR, CIK 0001804176
Ticker · exchangeBFLY · NYSESEC submissions data
Industry (SEC SIC)X-Ray Apparatus & Tubes & Related Irradiation ApparatusSEC EDGAR company profile
Incorporated inDESEC EDGAR company profile
Revenue, latest fiscal year$97.6 million · 1 January 2025 to 31 December 202510-K filed 2026-02-27 · XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax = 97,610,000 USD
Net income (loss), latest fiscal year-$77.1 million · 1 January 2025 to 31 December 202510-K filed 2026-02-27 · XBRL us-gaap:NetIncomeLoss = -77,064,000 USD
Revenue, latest reported quarter$32.6 million · 1 July 2026 to 30 September 202610-Q filed 2026-10-29 · XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax = 32,598,000 USD
Cash and cash equivalents$122.3 million · as of 30 September 202610-Q filed 2026-10-29 · XBRL us-gaap:CashAndCashEquivalentsAtCarryingValue = 122,301,000 USD
Latest results release8-K (Item 2.02) filed 29 October 2026SEC filing index
Latest annual report10-K for period ending 31 December 2025Filed 2026-02-27
Latest quarterly report (10-Q)10-Q for period ending 30 September 2026Filed 2026-10-29

Compare with Tempus AI and Hims & Hers →10 years forward calculator →

Revenue and share count

Revenue by quarter · last 8 reported quarters, US$
Butterfly Network quarterly revenue, 31 December 2024 to 30 September 2026$22.4MDec 24*$21.2MMar 25$23.4MJun 25$21.5MSep 25$31.5MDec 25*$26.5MMar 26$32.6MJun 26$32.6MSep 26

Source: SEC XBRL company facts from the 10-Q and 10-K filings, retrieved 16 November 2026. * Fourth quarter = fiscal-year total in the 10-K minus the three reported quarters (the 10-K does not report Q4 separately).

Data and sources
Period endValueSource
31 December 2024 *$22.4M · 22,352,00010-K filed 2026-02-27 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · derived
31 March 2025$21.2M · 21,225,00010-Q filed 2026-04-30 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
30 June 2025$23.4M · 23,383,00010-Q filed 2026-07-30 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
30 September 2025$21.5M · 21,489,00010-Q filed 2026-10-29 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
31 December 2025 *$31.5M · 31,513,00010-K filed 2026-02-27 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · derived
31 March 2026$26.5M · 26,530,00010-Q filed 2026-04-30 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
30 June 2026$32.6M · 32,612,00010-Q filed 2026-07-30 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
30 September 2026$32.6M · 32,598,00010-Q filed 2026-10-29 · us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

Recent SEC filings

Latest material filings from SEC EDGAR (annual, quarterly, current reports, registrations, proxies). Retrieved 16 November 2026.
FiledFormWhat it is
S-3ASRAutomatic shelf registration
10-QQuarterly report
8-KCurrent report: Results of operations
8-KCurrent report: Director or officer change
8-KCurrent report: Director or officer change
10-QQuarterly report
8-KCurrent report: Results of operations
8-KCurrent report: Shareholder vote results

SEC EDGAR

FAQ

What does Butterfly Network do?

Butterfly Network makes handheld point-of-care ultrasound devices built on its Ultrasound-on-Chip semiconductor platform, paired with cloud-connected software.

Sources: sec.gov/Archives/edgar/data/1804176/000180417626000009/bfly-20251231.htm

Where can I read Butterfly Network's official filings?

Butterfly Network files with the US Securities and Exchange Commission under CIK 0001804176. Its annual and quarterly reports are on SEC EDGAR.

Sources: sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001804176

When does Butterfly Network report results next?

Butterfly Network has not announced its next results date yet (TBA). This page shows a date only after the company announces it.

Sources: betthedecade.com/tools/earnings-calendar/

Which Bet The Decade episodes cover Butterfly Network?

Bet The Decade has covered Butterfly Network in 1 episode. The most recent is “What Is Butterfly Network Really Worth Now That AI Wants Its Chip?” (9 November 2026); its page has the video, chapters, the transcript and the sources.

Sources: betthedecade.com/episodes/what-is-butterfly-network-really-worth-now-that-ai-wants-its-chip/ · betthedecade.com/episodes/

What risks does Butterfly Network list in its filings?

In its 10-K filed 27 February 2026, Butterfly Network lists risks including: We have a limited history of generating revenue from sales of our products, and we have incurred significant losses since inception. We anticipate that we will continue to incur…; Our success depends upon market acceptance of our products and services, our ability to develop and commercialize existing and new products and services and generate revenues, and…; Medical device development is costly and involves continual technological change, which may render our current or future medical devices obsolete. The full list is in Item 1A (Risk Factors).

Sources: sec.gov/Archives/edgar/data/1804176/000180417626000009/bfly-20251231.htm

Is handheld ultrasound “AI diagnosis”?

Company markets AI-assisted guidance features; diagnosis remains a clinician responsibility. Not medical advice.

Sources: butterflynetwork.com/

What did Butterfly Network report for Q3 2026?

Butterfly Network reported Q3 2026 revenue of $32.6 million (+52% year over year) and raised FY2026 revenue guidance to $123–126 million; Q4 guidance is $31–34 million.

Sources: ir.butterflynetwork.com/News/press-releases/news-details/2026/Butterfly-Network- · sec.gov/Archives/edgar/data/1804176/000180417626000040/bfly-20260930.htm

Episodes

Related companies

Tempus AI (TEM) · Hims & Hers (HIMS) · 10x Genomics (TXG) · Nautilus Biotechnology (NAUT) · Recursion (RXRX) · ImmunityBio (IBRX) · CRISPR Therapeutics (CRSP)

Themes: Biotech

Guides and tools

Tools: 10-Year Calculator · Compare companies · Portfolio Growth Model

Page status: Complete. Last updated 16 November 2026.